Unlike T-ALL, activating NOTCH1 mutations in AML are rarely found; however, overexpression of Notch 1 and its ligands have been shown to be independent prognostic markers of overall patient survival [56,57,58,59]. The gene discussed is NOTCH1; the disease is acute lymphoblastic leukemia.